John D. Salamone

Affiliations: 
University of Connecticut, Storrs, CT, United States 
Area:
DA and motivation
Google:
"John Salamone"
Mean distance: 13.57 (cluster 19)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Correa M, SanMiguel N, López-Cruz L, et al. (2018) Caffeine Modulates Food Intake Depending on the Context That Gives Access to Food: Comparison With Dopamine Depletion. Frontiers in Psychiatry. 9: 411
Salamone JD, Correa M, Ferrigno S, et al. (2018) The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation. Pharmacological Reviews. 70: 747-762
López-Cruz L, Salamone JD, Correa M. (2018) Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression. Frontiers in Pharmacology. 9: 526
Acquas E, Salamone JD, Correa M. (2018) Editorial: Ethanol, Its Active Metabolites, and Their Mechanisms of Action: Neurophysiological and Behavioral Effects. Frontiers in Behavioral Neuroscience. 12: 95
SanMiguel N, Pardo M, Carratalá-Ros C, et al. (2018) Individual differences in the energizing effects of caffeine on effort-based decision-making tests in rats. Pharmacology, Biochemistry, and Behavior. 169: 27-34
Salamone JD, Correa M, Yang JH, et al. (2018) Dopamine, Effort-Based Choice, and Behavioral Economics: Basic and Translational Research. Frontiers in Behavioral Neuroscience. 12: 52
López-Cruz L, San Miguel N, Carratalá-Ros C, et al. (2018) Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns. Neuropharmacology
Contreras-Mora H, Rowland MA, Yohn SE, et al. (2018) Partial reversal of the effort-related motivational effects of tetrabenazine with the MAO-B inhibitor deprenyl (selegiline): Implications for treating motivational dysfunctions. Pharmacology, Biochemistry, and Behavior
Yohn SE, Reynolds S, Tripodi G, et al. (2017) The monoamine-oxidase B inhibitor deprenyl increases selection of high-effort activity in rats tested on a progressive ratio/chow feeding choice procedure: Implications for treating motivational dysfunctions. Behavioural Brain Research
Yohn SE, Gorka D, Mistry A, et al. (2017) Oral Ingestion and Intraventricular Injection of Curcumin Attenuates the Effort-Related Effects of the VMAT-2 Inhibitor Tetrabenazine: Implications for Motivational Symptoms of Depression. Journal of Natural Products
See more...